Stephen Glover

Stephen C.
Glover is the founder of ZyVersa Therapeutics Operating, Inc., founded in 2014, holding the title of Chairman & Chief Executive Officer.
Mr. Glover was the founder of Coherus Oncology, Inc., founded in 2010, holding the title of Chief Business Officer from 2010 to 2013.
Mr. Glover is the founder of ZyVersa Therapeutics, Inc., founded in 2014, holding the title of Chairman, President & Chief Executive Officer since 2022.
Mr. Glover is also the founder of Asclepius Life Sciences Fund LP..
Mr. Glover is currently Chairman at PDS Biotechnology Corp.
since 2019.
Mr. Glover is currently Director at Wallace H.
Coulter Foundation.
Mr. Glover is currently Director at Biogene Therapeutics, Inc. Mr. Glover is currently Director at Asclepius Life Sciences Fund LP.
Mr. Glover is currently Director at Inflamacore LLC.
Mr. Glover is currently Director at Two B Pharma.
Mr. Glover is currently Director at Oncolytics Biotech, Inc. starting in 2026.
Former positions include Chairman at Ambrx Biopharma Cayman, Inc. from 2023 to 2024.
Chairman at Ambrx, Inc. Chairman at PDS Operating Corp.
Director at INCON Co., Ltd. Director at Auriga Laboratories, Inc. Senior Vice President-Brand Operations at Andrx Corp.
from 2003 to 2006.
President at Insmed Therapeutic Proteins from 2007 to 2009.
Chief Business Officer & Executive Vice President at Insmed, Inc. from 2007 to 2010.
Senior Vice President & General Manager at Andrx Laboratories, Inc. Senior Vice President & General Manager at Watson Therapeutics, Inc. Principal at Amgen, Inc. Principal at IQVIA, Inc. Chief Business Officer at InteKrin Therapeutics, Inc. Principal at Hoffmann-La Roche, Inc. Education includes undergraduate degree(s) from Illinois State University, with a degree conferred in 1982.